Vera Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -19,550.0% | – | +36.4% | +60.0% | +129.2% | +54.5% | +40.0% | +8.4% | +4.7% | +89.6% | -48.4% | – | |
| – | +10.2% | +28.0% | +18.2% | +14.7% | +11.3% | +24.6% | +22.3% | +2.9% | +12.5% | +20.5% | +20.1% | – | |
| – | – | – | – | -4.6% | -112.4% | – | – | -35.1% | +19.3% | -232.5% | – | – | |
| – | – | -100.0% | – | +167.4% | +171.0% | -71.0% | +11.2% | -36.1% | -23.3% | +69.6% | -13.3% | – | |
| – | +14.3% | -1,281.8% | -89.7% | – | -677.8% | – | +86.4% | +144.4% | +15.6% | -270.9% | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8,259.6% | +1,013.8% | -98.8% | -78.5% | +44,007.6% | -99.5% | +1,223.2% | -96.1% | +35,819.9% | -98.6% | -51.3% | – | |
| – | – | +28.4% | -287.9% | – | +2,912.0% | -157.4% | – | – | +3,332.2% | -180.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.